company

LINDESNES APOTEK AS

4520 LINDESNES

Return on Equity
172,39 %
Current Ratio
1,22
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue23 797 000
Net Income1 998 000
Total Assets6 233 000
Total Equity1 159 000
Income (NOK)2022
Revenue23 797 000
Expenditure21 246 000
Operating Profit2 551 000
Financial Income11 000
Financial Costs0
Financial Balance11 000
Earnings Before Tax2 562 000
Tax564 000
Net Income1 998 000
Balance (NOK)2022
Total Fixed Assets26 000
Total Current Assets6 208 000
Total Assets6 233 000
Total Retained Equity1 129 000
Total Equity1 159 000
Total Long-Term Debt0
Total Current Debt5 075 000
Total Equity and Debt6 233 000
Cash flow (NOK)2022
Sales Income23 797 000
Other Income0
Revenue23 797 000
Cost of Goods Sold17 509 000
Salary Costs2 589 000
Depreciation4 000
Impairment0
Expenditure21 246 000
Operating Profit2 551 000
Financial Income11 000
Financial Costs0
Financial Balance11 000
Dividends2 000 000
Net Income1 998 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets13 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures12 000
Total Tangible Assets12 000
Total Fiancial Fixed Assets0
Total Fixed Assets26 000
Stock752 000
Total Investments0
Cash, Bank5 236 000
Total Current Assets6 208 000
Total Assets6 233 000
Total Equity1 159 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 889 000
Unpaid Taxes405 000
Dividends2 000 000
Other Current Debt222 000
Total Current Debt5 075 000
Total Equity and Debt6 233 000
Financial indicators2022
Return on Equity172,39 %
Debt-to-Equity Ratio0
Operating Profit Margin10,72 %
Current Ratio1,22
Quick Ratio1,44
Equity Ratio0,19
Gross Profit Margin26,42 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English